Filing Details
- Accession Number:
- 0001140361-17-037011
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-09-29 19:04:49
- Reporting Period:
- 2017-09-27
- Accepted Time:
- 2017-09-29 19:04:49
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1367644 | Emergent Biosolutions Inc. | EBS | Pharmaceutical Preparations (2834) | 141902018 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1380177 | Ronald Richard | 400 Professional Dr, Suite 400 Gaithersburg MD 20879 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-09-27 | 1,266 | $7.99 | 24,676 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-09-27 | 1,266 | $40.00 | 23,410 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2017-09-28 | 22,415 | $7.99 | 45,825 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-09-28 | 22,415 | $40.00 | 23,410 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (Right to buy) | Disposition | 2017-09-27 | 1,266 | $0.00 | 1,266 | $7.99 |
| Common Stock | Employee Stock Option (Right to buy) | Disposition | 2017-09-28 | 22,415 | $0.00 | 22,415 | $7.99 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 22,415 | 2018-05-21 | No | 4 | M | Direct | |
| 0 | 2018-05-21 | No | 4 | M | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Richard.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.05, inclusive.
- Consists of an option granted under the company's stock incentive plan as amended and restated.
- The option grant is fully vested.
Billionaire Hedge Funds
